Home > Balance Sheet > CORONA REMEDIES

CORONA REMEDIES
Contingent Liabilities

    Back to Balance Sheet
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Contingent Liabilities ₹1.01 Cr---

What is the latest Contingent Liabilities ratio of CORONA REMEDIES ?

The latest Contingent Liabilities ratio of CORONA REMEDIES is ₹1.01 Cr based on Mar2026 Consolidated results.
Year Contingent Liabilities
Mar2026₹1.01 Cr
Mar2025-
Mar2024-
Mar2023-

How is Contingent Liabilities of CORONA REMEDIES Trending?

Years Contingent Liabilities % Change
Mar2026 ₹1.01 Cr
0
Mar2025 -
0
Mar2024 -
0
Mar2023 - -

Compare Contingent Liabilities of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹13,456.4 Cr -1.7% 3.5% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹248,664.0 Cr 0.4% 9.9% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,738.0 Cr -3.4% -4.2% 37.1% Stock Analytics
CIPLA ₹110,794.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,749.4 Cr 0.9% 0% -11% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-1.7%

3.5%

NA
SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses